Control of paroxysmal atrial fibrillation recurrence using combined administration of propafenone and quinidine

American Journal of Cardiology

Volumn 86, Issue 12, 2000, Pages 1327-1332

  Lau, Chu Pak ^a   Chow, Moses S S ^b   Tse, Hung Fat ^a   Tang, Man Oi ^a   Fan, Chengda ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; CYTOCHROME P450 2D6; PROPAFENONE; QUINIDINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART PROARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPAFENONE; PROSPECTIVE STUDIES; QUINIDINE; RECURRENCE; SAFETY; TREATMENT OUTCOME;

EID: 0034672492     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)01236-4     Document Type: Article

References (25)

1. Atrial fibrillation
2. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials
3. Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias. A meta-analysis
4. Atrial fibrillation. Is there a safe and highly effective pharmacological treatment?
5. Quinidine
6. Usefulness of propafenone for recurrent paroxysmal atrial fibrillation
7. Intravenous propafenone for termination of reentrant supraventricular tachycardia. A placebo-controlled, randomized, double-blind, crossover study
8. Long-term oral propafenone therapy for suppression of refractory symptomatic atrial fibrillation and atrial flutter
9. A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm
10. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy
11. Propafenone for paroxysmal atrial fibrillation
12. Propafenone for conversion and prophylaxis of atrial fibrillation
13. Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring
14. A randomized double-blind crossover study comparing the efficacy and tolerability of flecainide and quinidine in the control of patients with symptomatic paroxysmal atrial fibrillation
15. Low-dose amiodarone for atrial fibrillation
16. Side effects from amiodarone
17. Pharmacologic therapy for reversion of atrial fibrillation and maintenance of sinus rhythm
18. Propafenone: A new antiarrhythmic agent
19. Polymorphism of propafenone metabolism and disposition in man: Clinical and pharmacokinetic consequences
20. Low frequency of slow debrisoquine hydroxylation in a native Chinese population
21. Enhanced antiarrhythmic efficacy of propafenone when used in combination with procainamide or quinidine
22. Combination of procainamide and quinidine for better tolerance and additive effects for ventricular arrhythmias
23. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease
24. Therapy of refractory symptomatic atrial fibrillation and atrial flutter: A staged care approach with new antiarrhythmic drugs
25. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter